GHI vs NBIX · rev $43.0M vs P/E 45, rev $1.77B
Greystone Housing Impact Investors LP (GHI) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Greystone Housing Impact Investors LP (GHI) is a mortgage finance company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported GHI revenue for 2026-06-30 was $43.0M. Net income was -$196.3K. Revenue was up 97.3% from 2026-03-31 to 2026-06-30. GHI currently screens at market cap $125.1M.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
GHI currently screens at market cap $125.1M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the GHI and NBIX stock pages for the full models.
Not investment advice.